[ad_1]
AAt the moment, none of the 175 vaccines that are being developed in the world have been approved for commercialization.
However, the approval of some of the vaccines should occur soon, at the end of this month or next, if there are no unforeseen events, Hugo recalled. Sigman, founder and director general of the pharmaceutical group Insud, which will produce the vaccine developed by the University of Oxford and AstraZeneca.
Statements of the pharmacist Hugo Sigman were held today during the online seminar organized by the Organization of Ibero-American States (OEI) and are being cited by the Spanish news agency EFE.
According to the pharmacist, it is not yet possible to know how long the antibodies of a vaccinated person will last, but it is expected to be at least a year, as is the case with the flu vaccine.
The University of Oxford vaccine, along with the Pfizer candidate and BioNTechque, are nowadays noted you have the best chance of being the first to be submitted for approval regulator.
“All the countries iberoamerican They are making very important purchase plans, ”said the pharmacist.
In Portugal, the Government authorized the purchase of 6.9 million vaccines against COVID-19-19, which will cost 20 million euros, through a process that is being coordinated between countries of the European Union (EU).
Regarding the criticisms of those who fear that the harm of taking a vaccine is greater than the benefits, the pharmacist guaranteed that the safety mechanisms are “very good” and that “the cost-benefit of being vaccinated is greater than that of not being vaccinated “.
OR objective is that at least 70% of the population is vaccinated to create group immunity.
The pharmacist recalled that the COVID-19-19 came to strengthen the process of making a type of vaccine that had already begun with the prevention of other coronavirus.
The laboratories were already working to combat SARS (Severe acute respiratory syndrome, which translates as severe acute respiratory syndrome in Portuguese), which was first identified in 2003, as well as the MERS (Middle East respiratory syndrome), which emerged in 2012.
Hugo Sigman I kept trusting the way that pandemic should evolve next year, since the measures for the treatment and prevention of the disease will already be known and because there will be more notification of cases asymptomatic, which can slow the spread of the virus.
A pandemic from COVID-19-19 has already caused more than 1.2 million deaths in more than 47.5 million cases of infection around the world, according to a report by the French agency AFP.
In Portugal, 2,694 people died out of 156,940 cases of infection confirmed, according to the most recent Address-General health.
The disease is transmitted by a new coronavirus detected not end of December of 2019, I Wuhan, a city in central China.
Always be the first to know.
Follow the chosen site for the fourth consecutive year Consumer Choice.
Download our free app.
[ad_2]
